作者
Eloy E Ordaya, Elena Beam, Joseph D Yao, Raymund R Razonable, Paschalis Vergidis
发表日期
2022/7/1
期刊
Open Forum Infectious Diseases
卷号
9
期号
7
页码范围
ofac283
出版商
Oxford University Press
简介
Tixagevimab-cilgavimab is authorized for preexposure prophylaxis against coronavirus disease 2019 (COVID-19) in immunocompromised hosts. Herein, we report the clinical characteristics of 8 patients who developed COVID-19 soon after receiving tixagevimab-cilgavimab. This study emphasizes the need to maintain additional measures to prevent COVID-19 during periods of high severe acute respiratory syndrome coronavirus 2 transmission.
学术搜索中的文章
EE Ordaya, E Beam, JD Yao, RR Razonable… - Open Forum Infectious Diseases, 2022